BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25370623)

  • 1. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Wu X
    Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paddle-based rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Dadkhah H; Bhatia SK; Buatti JM; Xu W; Wu X
    Med Phys; 2015 Oct; 42(10):5992-6003. PubMed ID: 26429274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multihelix rotating shield brachytherapy for cervical cancer.
    Dadkhah H; Kim Y; Wu X; Flynn RT
    Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid emission angle selection for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Yang W; Kim Y; Bhatia SK; Sun W; Wu X
    Med Phys; 2013 May; 40(5):051720. PubMed ID: 23635268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotating-shield brachytherapy for cervical cancer.
    Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
    Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast dose optimization for rotating shield brachytherapy.
    Cho M; Wu X; Dadkhah H; Yi J; Flynn RT; Kim Y; Xu W
    Med Phys; 2017 Oct; 44(10):5384-5392. PubMed ID: 28744870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
    Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
    Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
    Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization for high-dose-rate brachytherapy of cervical cancer with adaptive simulated annealing and gradient descent.
    Yao R; Templeton AK; Liao Y; Turian JV; Kiel KD; Chu JC
    Brachytherapy; 2014; 13(4):352-60. PubMed ID: 24359671
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Adams Q; Hopfensperger KM; Kim Y; Wu X; Flynn RT
    Med Phys; 2020 Dec; 47(12):6430-6439. PubMed ID: 33051866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse planning for combination of intracavitary and interstitial brachytherapy for locally advanced cervical cancer.
    Yoshio K; Murakami N; Morota M; Harada K; Kitaguchi M; Yamagishi K; Sekii S; Takahashi K; Inaba K; Mayahara H; Ito Y; Sumi M; Kanazawa S; Itami J
    J Radiat Res; 2013 Nov; 54(6):1146-52. PubMed ID: 23728322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SU-E-T-606: Optimal Emission Angle Selection in Rotating Shield Brachytherapy.
    Liu Y; Flynn R; Yang W; Kim Y; Wu X
    Med Phys; 2012 Jun; 39(6Part19):3845. PubMed ID: 28517084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of volume-based and inverse planning simulated annealing-based dose optimizations for high-dose rate brachytherapy.
    Pelagade S; Maddirala HR; Misra R; Suryanarayan U; Neema JP
    Med Dosim; 2015; 40(3):235-9. PubMed ID: 25795565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
    Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.